0001213900-24-008559.txt : 20240131 0001213900-24-008559.hdr.sgml : 20240131 20240131182858 ACCESSION NUMBER: 0001213900-24-008559 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240129 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shenouda Maged CENTRAL INDEX KEY: 0001658369 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39082 FILM NUMBER: 24584365 MAIL ADDRESS: STREET 1: 305 WEST 18TH STREET, APT 4B CITY: NEW YORK STATE: NY ZIP: 10011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001553643 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 455401931 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: 646 876 3459 MAIL ADDRESS: STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CAMP NINE, INC. DATE OF NAME CHANGE: 20120706 4 1 ownership.xml X0508 4 2024-01-29 0 0001553643 RELMADA THERAPEUTICS, INC. RLMD 0001658369 Shenouda Maged C/O RELMADA THERAPEUTICS, INC. 2222 PONCE DE LEON BLVD, 3RD FLOOR CORAL GABLES, FL 33134 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-01-29 4 P 0 10800 3.6528 A 13028 D Common Stock 2024-01-30 4 P 0 15000 3.8882 A 28028 D Common Stock 2024-01-31 4 P 0 6875 4.0645 A 34903 D The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $3.57 to $3.745 per share, inclusive. Purchase prices range from $3.82 to $3.90 per share, inclusive. Purchase prices range from $3.95 to $4.18 per share, inclusive. /s/ Maged Shenouda 2024-01-31